Today, the President & CEO of ANI Pharmaceuticals Inc (ANIP), Arthur Przybyl, sold shares of ANIP for $2.1M.
Following Arthur Przybyl’s last ANIP Sell transaction on March 20, 2019, the stock climbed by 5.3%. In addition to Arthur Przybyl, 3 other ANIP executives reported Sell trades in the last month.
See today’s analyst top recommended stocks >>
Based on ANI Pharmaceuticals Inc’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $52.89 million and quarterly net profit of $440K. In comparison, last year the company earned revenue of $46.48 million and had a net profit of $2.24 million. ANIP’s market cap is $839.6M and the company has a P/E ratio of 60.34. Currently, ANI Pharmaceuticals Inc has an average volume of 145.4K.
Based on 3 analyst ratings, the analyst consensus is Strong Buy with an average price target of $84.00, reflecting a 21.5% upside.
In the last 30 days, insiders have sold $2.62M worth of ANIP shares and purchased $173.2K worth of ANIP shares. The insider sentiment on ANI Pharmaceuticals Inc has been negative according to 35 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.
Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
ANI Pharmaceuticals, Inc. is a pharmaceutical company, which engages in developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended release and combination products.
